2026-09-15 23:30:35
Berenberg Upgrades Eli Lilly to Buy, Raises Price Target to $1,400 on September 15
According to CNBC on September 15, Berenberg upgraded Eli Lilly (NYSE: LLY) to Buy from Hold and raised its price target to $1,400 from $1,220. Berenberg analyst Cary Holford cited strong investor confidence in Eli Lilly's dominance in the fast-growing obesity treatment market. The stock has